With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (L LMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Significance, diagnostics and treatment options for cardiology practice
Coronary artery spasm and atherosclerosis
- Smoldering multiple myeloma
Daratumumab delays progression in smoldering multiple myeloma
- Invitation to the 12th IBD Roadshow | June 23-25, 2025 | with Professor Bruce Sands
Acceleration in IBD Treatment: How early and holistic care leads to better outcomes
- Chronic hand eczema
Changing therapy landscape – a lot is happening
- Chronic obstructive pulmonary disease
Polygenic risk score can help identify COPD
- Bronchiectasis and Pseudomonas aeruginosa infection
Statistically significant reduction in the frequency of exacerbations
- Journal Club
Case-control study on post-Covid syndrome
- Late-onset autoimmune diabetes (LADA)